한글목차

자가수혈 시스템 동향 및 전망

세계 자가수혈 시스템 시장은 심장 수술, 정형외과 수술, 장기 이식, 외상 치료 시장의 기회로 인해 미래가 유망한 시장입니다. 세계 자가수혈 시스템 시장은 2024년부터 2030년까지 연평균 5.3%의 성장률을 보일 것으로 예상됩니다. 이 시장의 주요 촉진요인은 이식 및 수술 건수 증가, 대중의 건강 인식 증가, 심혈관질환 및 혈관 질환의 증가입니다.

• Lucintel의 예측에 따르면, 제품별로는 예측 기간 동안 자가수혈 제품이 계속해서 더 큰 부문을 차지할 것으로 보입니다.
• 이 시장에서 용도별로는 심장 질환의 유병률 증가와 심장 수술에서 자가수혈의 제안으로 인해 심장 수술이 가장 큰 부문을 차지할 것으로 보입니다.
• 지역별로는 미국과 캐나다의 암 발병률 증가와 지방 정부의 암 인식 제고 활동으로 인해 북미가 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

자가수혈 시스템 시장에서의 전략적 성장 기회

헬스케어 업계가 보다 효율적이고 비용 효율적인 혈액 관리 솔루션을 모색함에 따라 자가혈 수혈 시스템 시장에는 수많은 전략적 성장 기회가 존재하고 있습니다. 전 세계적으로 외과 수술이 증가하고 환자 안전에 대한 관심이 높아지면서 시장 확대 가능성이 큽니다. 이 분야의 기업들은 기술 혁신, 지리적 확장, 특수 제품 개발을 통해 이러한 기회를 활용하기 위해 노력하고 있습니다.

• 신흥 시장으로의 지리적 확장 : 특히 아시아태평양, 라틴아메리카, 중동 등 헬스케어 인프라가 성장하고 있는 신흥국 시장으로의 진출은 시장 성장의 큰 기회로 작용하고 있습니다.
• 틈새용도에 특화된 기기 개발 : 특정 수술이나 환자군(소아, 노인 등)에 특화된 자가수혈 시스템 개발은 성장 잠재력을 가지고 있습니다.
• AI 및 자동화 도입 확대 : 인공지능과 자동화를 자가수혈 시스템에 통합하면 효율성을 높이고 시스템 기능을 강화하며 운영 비용을 절감할 수 있어 혁신 중심의 성장 기회를 창출할 수 있습니다.
• 파트너십 및 협업 : 병원, 연구기관, 의료기기 기업과의 전략적 파트너십을 통해 첨단 기술 개발을 촉진하고 시장 개발을 확대할 수 있습니다.
• 혈액 보존 및 지속가능성 중시 : 헬스케어 분야에서 지속가능성과 자원 최적화가 두드러지면서 환경 친화적인 기능을 제공하고 외부 혈액은행에 대한 의존도를 낮추는 자가수혈 시스템에 대한 수요가 증가하고 있습니다.

자가수혈 시스템 시장은 다양한 전략적 기회로 인해 크게 성장할 것으로 예상됩니다. 신흥국 시장 진출, AI 및 자동화와 같은 신기술 도입, 특수 장비 개발 등이 주요 성장 분야입니다. 이러한 기회를 활용하는 기업은 헬스케어 부문의 진화하는 요구에 부응하면서 점점 더 경쟁이 치열해지는 시장에서 성공할 수 있는 좋은 위치에 서게 될 것입니다.

자가수혈 시스템 시장의 촉진요인 및 과제

자가수혈 시스템 시장은 성장 궤도에 영향을 미치는 시장 촉진요인과 도전 과제의 조합에 의해 형성되고 있습니다. 자가수혈 시스템의 채택은 안전성과 효율성의 장점으로 인해 증가하는 추세이지만, 몇 가지 요인이 시장 역학에 영향을 미치고 있습니다. 이러한 촉진요인과 과제를 이해하는 것은 진화하는 이 분야의 복잡성을 극복하고자 하는 이해관계자들에게 필수적입니다.

자가수혈 시스템 시장의 촉진요인은 다음과 같습니다.

• 수술 절차의 증가 : 수술 건수의 증가, 특히 대량 출혈을 동반한 수술 건수의 증가는 자가수혈 시스템에 대한 수요를 촉진하고 있습니다.
• 환자 안전에 대한 관심 증가 : 기존 수혈과 관련된 위험을 최소화하고 헌혈에 대한 의존도를 줄이려는 욕구가 자가수혈 시스템의 채택을 촉진하고 있습니다.
• 기술 발전 : 시스템 설계, 자동화 및 다른 의료 기술과의 통합에 대한 혁신은 자가수혈 시스템을 의료 서비스 제공자에게 더욱 매력적으로 만들고 있습니다.
• 혈액 보존에 대한 인식 증가 : 혈액 보존에 대한 인식이 높아지면서 병원과 수술 센터에서 자가수혈 시스템 사용을 촉진하고 있습니다.
• 혈액 관리에 대한 규제 지원 : 보건 당국의 지원적인 규제와 정책은 많은 수술에서 자가수혈 시스템을 표준 치료법으로 채택하도록 장려하고 있습니다.

과제:

• 높은 초기 비용 : 특히 비용에 민감한 의료 환경에서는 자가수혈 시스템 도입의 초기 비용이 장벽이 될 수 있습니다.
• 기술적 복잡성 : 고급 자가수혈 시스템의 운영 및 유지보수에는 전문적인 교육이 필요하기 때문에 보급이 제한될 수 있습니다.
• 대체 혈액 관리 솔루션과의 경쟁 : 대체 혈액 및 세포 회수 기술과 같은 경쟁은 자가수혈 시스템에 경쟁 압력을 가합니다.

자가수혈 시스템 시장은 수술 건수 증가, 환자 안전에 대한 관심 증가, 지속적인 기술 발전 등의 요인에 의해 주도되고 있습니다. 그러나 높은 비용, 기술의 복잡성, 규제적 장애물 등은 여전히 보급에 걸림돌로 작용하고 있습니다. 시장 촉진요인과 과제를 해결하면서 성장 요인을 활용하는 것이 시장 모멘텀을 지속하고 지속적인 성공을 보장하는 열쇠가 될 것입니다.

목차

제1장 주요 요약

제2장 세계의 자가수혈 시스템 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 자가수혈 시스템 시장 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 자가수혈 시스템 시장(유형별)
  • 자가수혈 제품
  • 자가수혈용 액세서리
• 세계 자가수혈 시스템 시장 : 용도별
  • 심장 수술
  • 정형외과 수술
  • 장기 이식
  • 외상 시술
  • 기타

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 세계 자가수혈 시스템 시장 : 지역별
• 북미의 자가수혈 시스템 시장
• 유럽의 자가수혈 시스템 시장
• 아시아태평양의 자가수혈 시스템 시장
• 기타 지역의 자가수혈 시스템 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 자가수혈 시스템 시장 유형별 성장 기회
  • 세계의 자가수혈 시스템 시장 용도별 성장 기회
  • 세계의 자가수혈 시스템 시장 지역별 성장 기회
• 세계의 자가수혈 시스템 시장 최신 동향
• 전략 분석
  • 신제품 개발
  • 세계의 자가수혈 시스템 시장 능력 확대
  • 세계의 자가수혈 시스템 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• LivaNova
• Fresenius
• Haemonetics
• Medtronic
• Becton, Dickinson & Company
• Teleflex
• Atrium Medical

영문목차

Autotransfusion System Trends and Forecast

The future of the global autotransfusion system market looks promising with opportunities in the cardiac surgeries, orthopedic surgeries, organ transplantation, and trauma procedures markets. The global autotransfusion system market is expected to grow with a CAGR of 5.3% from 2024 to 2030. The major drivers for this market are the growing number of transplant and surgery operations, rising health awareness among the population, as well as, increasing rates of cardiovascular and vascular disorders.

• Lucintel forecasts that, within the type category, autotransfusion products will remain a larger segment over the forecast period.
• Within this market, within the application category, cardiac surgeries will remain the largest segment due to the elevated incidence of heart diseases and suggestions for self-blood transfusion in cardiac procedures.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to growing cancer rates in the United States and Canada, alongside cancer awareness efforts led by local authorities.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Autotransfusion System Market

The field of autotransfusion systems has witnessed significant advancements in recent years, driven by the increasing need for safer and more efficient blood management in clinical settings. As medical procedures become more complex, the demand for innovative solutions in transfusion medicine is growing. This has led to emerging trends that aim to improve patient outcomes, reduce healthcare costs, and enhance the overall efficacy of blood conservation during surgeries.

• Integration with Advanced Monitoring Systems: New autotransfusion systems are increasingly being integrated with real-time monitoring tools for better blood management and precise control during procedures.
• Minimally Invasive Techniques: With the rise of minimally invasive surgery, autotransfusion systems are evolving to accommodate smaller incisions and reduced recovery times.
• Automation and Artificial Intelligence: Automation and AI technologies are being incorporated to optimize the blood collection, processing, and reinfusion process, minimizing human error and maximizing efficiency.
• Portable and Compact Devices: Portable autotransfusion devices are emerging, allowing for more flexibility in medical settings and improving the accessibility of blood recovery technologies.
• Focus on Patient Safety and Quality: Innovations focus on ensuring the purity and safety of transfused blood, minimizing the risk of contamination, and optimizing patient outcomes.

The autotransfusion system market is rapidly evolving, with emerging trends focusing on technological integration, patient safety, and efficiency. The industry is witnessing a shift toward automation, portability, and improved blood management strategies, which are set to enhance the future of transfusion medicine. As these trends continue to shape the market, they promise to contribute significantly to patient care and the overall healthcare ecosystem.

Recent Developments in the Autotransfusion System Market

Recent developments in the autotransfusion system market have been driven by a combination of technological innovations and growing demands for safer, more efficient blood management. As healthcare providers strive to reduce the risks associated with traditional blood transfusions, the adoption of autotransfusion systems has surged. These developments are enhancing clinical outcomes, streamlining medical procedures, and addressing challenges in blood supply.

• Technological Advancements in Blood Processing: New systems now incorporate more advanced filters and processing units to enhance the quality of recovered blood, reducing the risk of transfusion-related complications.
• Regulatory Approvals for New Devices: Several new autotransfusion devices have received regulatory approvals, expanding the available range of options for healthcare facilities.
• Expansion of Product Portfolios by Key Players: Major companies in the autotransfusion market have expanded their product portfolios, offering a wider variety of devices that cater to different surgical settings and patient needs.
• Integration with Electronic Health Records (EHR): Modern systems are now integrating seamlessly with EHR systems, providing healthcare professionals with real-time access to patient data, which improves decision-making and workflow.
• Increased Focus on Cost-Effectiveness: As healthcare systems increasingly prioritize cost-effectiveness, autotransfusion devices are becoming more affordable, ensuring broader adoption across hospitals and clinics.

Recent developments in the autotransfusion system market highlight the industry's ongoing innovation and commitment to improving blood management. From regulatory approvals to advanced technological features, these changes are driving the adoption of autotransfusion systems in diverse healthcare settings. These developments are not only enhancing patient safety and procedural outcomes but also addressing the broader challenges of cost and efficiency in modern healthcare.

Strategic Growth Opportunities for Autotransfusion System Market

The autotransfusion system market presents numerous strategic growth opportunities as the healthcare industry seeks more efficient and cost-effective solutions for blood management. With increasing surgical procedures worldwide and a growing focus on patient safety, there is substantial potential for market expansion. Companies operating in the sector are positioning themselves to capitalize on these opportunities through innovation, geographical expansion, and the development of specialized products.

• Geographical Expansion into Emerging Markets: Expanding into developing regions with growing healthcare infrastructures presents a significant opportunity for market growth, particularly in Asia-Pacific, Latin America, and the Middle East.
• Development of Specialized Devices for Niche Applications: Developing autotransfusion systems tailored to specific surgical procedures or patient demographics (e.g., pediatric or geriatric patients) offers growth potential.
• Increased Adoption of AI and Automation: The integration of artificial intelligence and automation into autotransfusion systems can drive efficiency, enhance system capabilities, and reduce operational costs, presenting opportunities for innovation-driven growth.
• Partnerships and Collaborations: Strategic partnerships with hospitals, research institutions, and medical device companies can facilitate the development of cutting-edge technologies and increase market reach.
• Focus on Blood Conservation and Sustainability: As sustainability and resource optimization becomes more prominent in healthcare, autotransfusion systems that offer eco-friendly features and reduced reliance on external blood banks will see higher demand.

The autotransfusion system market is poised for significant growth driven by various strategic opportunities. Expanding into emerging markets, embracing new technologies like AI and automation, and developing specialized devices are key growth areas. Companies that capitalize on these opportunities will be well-positioned to thrive in an increasingly competitive market while addressing the evolving needs of the healthcare sector.

Autotransfusion System Market Driver and Challenges

The autotransfusion system market is shaped by a combination of drivers and challenges that impact its growth trajectory. While the adoption of autotransfusion systems is on the rise due to their safety and efficiency benefits, several factors are influencing market dynamics. Understanding these drivers and challenges is essential for stakeholders seeking to navigate the complexities of this evolving sector.

Drivers of the autotransfusion system market are as follows:

• Increasing Surgical Procedures: The growing number of surgeries, especially those involving high blood loss, drives the demand for autotransfusion systems.
• Enhanced Patient Safety Concerns: The desire to minimize the risks associated with traditional blood transfusions and reduce reliance on donated blood is driving the adoption of autotransfusion systems.
• Technological Advancements: Innovations in system design, automation, and integration with other medical technologies are making autotransfusion systems more attractive to healthcare providers.
• Rising Awareness of Blood Conservation: Increasing awareness about blood conservation practices is promoting the use of autotransfusion systems in hospitals and surgical centers.
• Regulatory Support for Blood Management: Supportive regulations and policies from health authorities are encouraging the adoption of autotransfusion systems as a standard of care in many surgical procedures.

Challenges:

• High Initial Costs: The upfront cost of acquiring and implementing autotransfusion systems can be a barrier, particularly in cost-sensitive healthcare settings.
• Technical Complexity: The operation and maintenance of advanced autotransfusion systems require specialized training, which can limit their widespread adoption.
• Competition from Alternative Blood Management Solutions: Alternatives like blood substitutes or cell-salvage technologies present competitive pressures to autotransfusion systems.

The autotransfusion system market is driven by factors such as increased surgical volumes, heightened patient safety concerns, and ongoing technological advancements. However, challenges like high costs, technical complexity, and regulatory hurdles remain obstacles to widespread adoption. Addressing these challenges while capitalizing on the drivers of growth will be key to sustaining the momentum of the market and ensuring its continued success.

List of Autotransfusion System Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies autotransfusion system companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the autotransfusion system companies profiled in this report include-

• LivaNova
• Fresenius
• Haemonetics
• Medtronic
• Becton, Dickinson & Company
• Teleflex
• Atrium Medical

Autotransfusion System by Segment

The study includes a forecast for the global autotransfusion system by type, application, and region.

Autotransfusion System Market by Type [Analysis by Value from 2018 to 2030]:

• Autotransfusion Products
• Autotransfusion Accessories

Autotransfusion System Market by Application [Analysis by Value from 2018 to 2030]:

• Cardiac Surgeries
• Orthopedic Surgeries
• Organ Transplantation
• Trauma Procedures
• Other

Autotransfusion System Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Autotransfusion System Market

The autotransfusion system market has seen significant advancements driven by technological innovations, increasing surgical procedures, and a growing emphasis on patient safety. Autotransfusion systems, which allow for the collection and reinfusion of a patient's blood, are becoming increasingly popular in various medical settings. Countries like the United States, China, Germany, India, and Japan are at the forefront of these developments, implementing new technologies and practices that enhance efficiency and safety in blood management.

• United States: Recent trends in the U.S. focus on the implementation of modern techniques in the field of autotransfusion systems. A growing trend is the emergence of mobile and user-friendly devices, such as blood collection devices and blood reinfusion pumps. Furthermore, there is an increased focus on educating healthcare providers on how to use these systems optimally to improve patient care.
• China: Driven by heightened healthcare needs and governmental support for healthcare technology, the autotransfusion system market in China is experiencing explosive growth. Key developments include the design and creation of an advanced blood apparatus that not only improves the quality of care for patients but also optimizes operational performance. Additionally, pharmaceutical companies are promoting products tailored to the needs of local hospitals and clinics through advertising and targeted marketing efforts.
• Germany: German hospitals have made significant progress in the development of autotransfusion devices, particularly through innovations in blood recycling and irrigation systems. The government has also contributed to the adoption of such equipment by formulating laws that prioritize patient welfare and the efficient use of blood. This has led to broader usage of these devices, facilitating their quicker adoption in operating rooms.
• India: The growth of the autotransfusion system market in India is mainly attributed to the increasing number of surgical procedures and a strong focus on patient safety. Recent developments include the introduction of low-cost autotransfusion devices tailored to the local market. Companies are also expanding their distribution channels to improve accessibility within hospitals and clinics across the country.
• Japan: The autotransfusion system market in Japan is primarily driven by technological advancements, innovations, and a focus on meeting patient needs. Recent breakthroughs include the launch of fully automated blood processing devices that help minimize blood contamination while increasing the speed at which blood is returned to patients after surgery. The market is growing rapidly due to strong support from both manufacturers and healthcare institutions.

Features of the Global Autotransfusion System Market

Market Size Estimates: Autotransfusion system market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Autotransfusion system market size by type, application, and region in terms of value ($B).

Regional Analysis: Autotransfusion system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the autotransfusion system market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the autotransfusion system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the autotransfusion system market by type (autotransfusion products and autotransfusion accessories), application (cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, and other), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Autotransfusion System Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Autotransfusion System Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Autotransfusion System Market by Type
  • 3.3.1: Autotransfusion Products
  • 3.3.2: Autotransfusion Accessories
• 3.4: Global Autotransfusion System Market by Application
  • 3.4.1: Cardiac Surgeries
  • 3.4.2: Orthopedic Surgeries
  • 3.4.3: Organ Transplantation
  • 3.4.4: Trauma Procedures
  • 3.4.5: Other

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Autotransfusion System Market by Region
• 4.2: North American Autotransfusion System Market
  • 4.2.1: North American Market by Type: Autotransfusion Products and Autotransfusion Accessories
  • 4.2.2: North American Market by Application: Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Other
• 4.3: European Autotransfusion System Market
  • 4.3.1: European Market by Type: Autotransfusion Products and Autotransfusion Accessories
  • 4.3.2: European Market by Application: Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Other
• 4.4: APAC Autotransfusion System Market
  • 4.4.1: APAC Market by Type: Autotransfusion Products and Autotransfusion Accessories
  • 4.4.2: APAC Market by Application: Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Other
• 4.5: ROW Autotransfusion System Market
  • 4.5.1: ROW Market by Type: Autotransfusion Products and Autotransfusion Accessories
  • 4.5.2: ROW Market by Application: Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Other

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Autotransfusion System Market by Type
  • 6.1.2: Growth Opportunities for the Global Autotransfusion System Market by Application
  • 6.1.3: Growth Opportunities for the Global Autotransfusion System Market by Region
• 6.2: Emerging Trends in the Global Autotransfusion System Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Autotransfusion System Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Autotransfusion System Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: LivaNova
• 7.2: Fresenius
• 7.3: Haemonetics
• 7.4: Medtronic
• 7.5: Becton, Dickinson & Company
• 7.6: Teleflex
• 7.7: Atrium Medical